Kathleen Laporte

Kathleen Laporte has an estimated net worth of $20.1 Million. This is based on reported shares across multiple companies, which include eHealth, Inc., CERO THERAPEUTICS HOLDINGS, INC., Precipio, Inc., 89bio, Inc., Bolt Biotherapeutics, Inc., Transcept Pharmaceuticals Inc, AFFYMAX INC, WORLD HEART CORP, ISTA PHARMACEUTICALS INC, ADEZA BIOMEDICAL CORP, VNUS MEDICAL TECHNOLOGIES INC, and Q32 Bio Inc..

2024 was Kathleen Laporte's most active year for acquiring shares with 21 total transactions. Kathleen Laporte's most active month to acquire stocks was the month of November. 2004 was Kathleen Laporte's most active year for disposing of shares, totalling 21 transactions. Kathleen Laporte's most active month to dispose stocks was the month of September. 2005 saw Kathleen Laporte paying a total of $7,641,120.00 for 883,500 shares, this is the most they've acquired in one year. In 2011 Kathleen Laporte cashed out on 4,761,429 shares for a total of $27,268,449.57, their largest year based on trade value.